Pharmacologic<unk><unk>  is recommended among patients with infantile onset glycogen storage type 2 (GSD type 2). Pharmacologic<unk> <unk> es for GSD type 2 include enzyme replacement<unk>  (ERT) with recombinant human acid alpha-glucosidase.
Glycogen storage disease type II medical therapy
Glycogen storage disease type I medical therapy
Glycogen storage disease type III medical therapy
Glycogen storage disease type I secondary prevention
Glycogen storage disease type II secondary prevention
Glycogen storage disease type I primary prevention
Glycogen storage disease type III secondary prevention
Glycogen storage disease type II primary prevention